Want to join the conversation?
$ISRG said 2Q16 instrument and accessory revenue grew by approx. 14% to $339MM versus $297MM in 2Q15, mainly driven by nearly 16% growth in da Vinci procedure volume. Systems revenue increased by about 15% to $203MM compared with $176MM last year. Services revenue grew by 13% to $128.1MM versus $113.3MM in 2Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?